Kopans Receives the Kushner Writing Award

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 10
Volume 5
Issue 10

BETHESDA, Md--Daniel B. Kopans, MD, of the Department of Radiology, Massachusetts General Hospital and Harvard Medical School, has received the 1996 Rose Kushner Award for Writing Achievement in the Field of Breast Cancer for best scientific article.

BETHESDA, Md--Daniel B. Kopans, MD, of the Department of Radiology,Massachusetts General Hospital and Harvard Medical School, hasreceived the 1996 Rose Kushner Award for Writing Achievement inthe Field of Breast Cancer for best scientific article.

His contribution, Mammography screening and the controversy concerningwomen aged 40 to 49, appeared in Radiologic Clinics of North America.

Other winners of the Kushner awards, sponsored by the AmericanMedical Writers Association and Zeneca Pharmaceuticals, were HeidiRosvold-Brenholtz for best lay article (Breast health, NationalWomen's Health Report) and Robin Y. Wood, EdD, for best script(Breast health for women over 60, HealthWood, Inc.).

Also, Diane Robertson-Steele for best brochure or monograph (High-dosechemotherapy with bone marrow transplant for metastatic breastcancer, ECRI) and Rita Baron-Faust for best book (Breast Cancer:What Every Woman Should Know (Hearst/William Morrow &Co.).

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.